Viridian Therapeutics, Inc.\DE (VRDN) Gross Margin (2013 - 2016)
Viridian Therapeutics, Inc.\DE (VRDN) reported Gross Margin of -35.95% for Q4 2016, down 66.76 percentage points from 30.80% a year earlier and down 71.96 percentage points from the prior quarter.
Powered by 
Analysis
Viridian Therapeutics, Inc.\DE (VRDN) Gross Margin (2013 - 2016) Analysis & Trends
For FY2016, Viridian Therapeutics, Inc.\DE posted Gross Margin of 26.72%, up 24.12 percentage points from FY2015.
- By year, Gross Margin came in at 2.60% in FY2015 (-45.49 pp) and 48.09% in FY2014.
- The Q4 2016 figure ranks as the lowest quarterly Gross Margin in data going back to Q2 2013.
- Year over year, Gross Margin gained in two of the last eight quarters, with an average year-over-year change of -14.61 percentage points.
- The high point for year-over-year Gross Margin in five years was Q3 2016 (a gain of 51.17 percentage points); the low point was Q3 2015 (a drop of 67.09 percentage points).
- Per Business Quant data, the three quarters before Q4 2016 came in at 36.00% (Q3 2016), 43.68% (Q2 2016) and 31.41% (Q1 2016).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 85.78% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 68.19% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 74.74% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 73.54% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 78.02% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 83.60% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 72.04% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 79.76% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 72.78% |
| 10 | Viridian Therapeutics, Inc.\DE | 2.20 Bn | 2.20 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2016 | -35.95% |
| Sep 30, 2016 | 36.00% |
| Jun 30, 2016 | 43.68% |
| Mar 31, 2016 | 31.41% |
| Dec 31, 2015 | 30.80% |
| Sep 30, 2015 | -15.17% |
| Jun 30, 2015 | 53.47% |
| Mar 31, 2015 | 42.29% |
| Dec 31, 2014 | 48.18% |
| Sep 30, 2014 | 51.92% |
| Jun 30, 2014 | 41.15% |
| Mar 31, 2014 | 50.74% |
| Sep 30, 2013 | 50.35% |
| Jun 30, 2013 | 51.33% |
API Access
Viridian Therapeutics, Inc.\DE Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=VRDN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "VRDN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=VRDN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();